成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Brigatinib

Brigatinib Struktur
1197953-54-0
CAS-Nr.
1197953-54-0
Englisch Name:
Brigatinib
Synonyma:
Brig;AP26113 (Brigatinib);140455;atinib;brigatib;Bri atinib;Brigatinib;Bouguer for;Brigatinib API;Bogtinib (AP26113)
CBNumber:
CB43041390
Summenformel:
C29H39ClN7O2P
Molgewicht:
584.09
MOL-Datei:
1197953-54-0.mol

Brigatinib Eigenschaften

Schmelzpunkt:
>203°C (dec.)
Siedepunkt:
781.8±70.0 °C(Predicted)
Dichte
1.31±0.1 g/cm3(Predicted)
storage temp. 
-20°C
L?slichkeit
Soluble in DMSO (1 mg/ml with warming)
Aggregatzustand
solid
pka
8.14±0.42(Predicted)
Farbe
White to off-white
Stabilit?t:
Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
InChIKey
AILRADAXUVEEIR-UHFFFAOYSA-N
SMILES
C1(NC2=CC=C(N3CCC(N4CCN(C)CC4)CC3)C=C2OC)=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1
CAS Datenbank
1197953-54-0
Sicherheit
  • Risiko- und Sicherheitserkl?rung
  • Gefahreninformationscode (GHS)
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitssch?dlich bei Verschlucken. Akute Toxizit?t oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizit?t (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
Sicherheit
P261 Einatmen von Staub vermeiden.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen.

Brigatinib Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Brigatinib is a small molecule inhibitor of both ALK and EGFR [195]. In preclinical models, “triple-mutant EGFR”-positive cells (activating EGFR mutation/ T790M/C797S) responded to the combination of brigatinib with an anti-EGFR monoclonal antibody, cetuximab or panitumumab [196]. Single-agent activity of brigatinib in a phase I/II trial was only 5% [197], possibly compounded by low plasma concentrations [196], but the addition of an anti-EGFR monoclonal antibody remains to be clinically tested. The preclinical data with brigatinib and EAI045?in laboratory models with a C797S mutation demonstrate that combination therapies with an anti-EGFR monoclonal antibody may lead to overcoming resistance to osimertinib.

Trademarks

Alunbrig?

Brigatinib Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Brigatinib Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 307)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
AFINE CHEMICALS LIMITED
+86-0571-85134551
sales@afinechem.com China 15352 58
Zhengzhou Anhuida Chemical Co., Ltd
+8615903659408
admin@ahdchem.com China 286 58
Jinan Good Medical Technology Co.,Ltd
+86-53155562571 +86-008613553167512
13553167512@139.com China 23 58
Enki Biopharmaceuticals (Shanghai) Limited
+86-0086-2157680326 +8613916707528
yusu@enkibiopharma.com China 48 58
Hebei Yanxi Chemical Co., Ltd.
+8617531190177
peter@yan-xi.com China 5857 58
Shaanxi Haibo Biotechnology Co., Ltd
+undefined18602966907
qinhe02@xaltbio.com China 997 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618092446649
sarah@tnjone.com China 1143 58
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
+86-18600796368 +86-18600796368
sales@sjar-tech.com China 456 58
Cangzhou Kangrui Pharma Tech Co. Ltd.,
+86-18632776803 +86-13833998158
cangzhoukangrui@126.com China 738 58
Capot Chemical Co.,Ltd.
+86-(0)57185586718 +86-13336195806
sales@capot.com China 29791 60

  • Brigatinib
  • Brigatinib, AP26113
  • 5-Chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-pyrimidinediamine
  • atinib
  • Bri atinib
  • 2,4-Pyrimidinediamine, 5-chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-
  • Brigatinib USP/EP/BP
  • 1197953-54-0 Brigatinib
  • Brigatinib - AP 26113 | Alunbrig
  • Bogtinib (AP26113)
  • 140455
  • brigatib
  • 5-chloro-N4-(2-(dimethylphosphoryl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine
  • AP26113 (Brigatinib)
  • Brig
  • Bouguer for
  • Brigatinib API
  • Serpatinib LOXO-292
  • 1197953-54-0
  • 197953-54-0
  • C29H39ClN7O2P
  • API
  • 1197953-54-0
Copyright 2019 ? ChemicalBook. All rights reserved